Table of Contents Table of Contents
Previous Page  146 / 220 Next Page
Information
Show Menu
Previous Page 146 / 220 Next Page
Page Background

been missed by conventional treatment of ipsilateral

neck dissection.

In head and neck cancer, historically, there has been

concern that biopsy of suspected neck metastasis

would facilitate dissemination of tumour in the neck.

A systematic review

[20]

of 109 papers calculated

regional recurrence rates of 13% in surgically treated

early-stage oral cancer. A further review of 164

[21]

patients with pT1

e

T2 tongue SCC staged pN0 after

END reported a regional recurrence rate of 18%. The

results of SENT when reported in an identical

way show the neck recurrence rate for SNB and

SNB

þ

and the total group were 5%, 15% and 7.5%.

The low rate of regional recurrence argues against

SNB causing tumour spillage and in turn neck

recurrence.

Two- and 5-year overall survival in early oral and

oropharyngeal carcinoma is in the region of 82% and

76%, respectively

[20,22]

. In this study, overall crude

(88%) and DSS (94%) are unlikely to change signifi-

cantly and suggest strongly that SNB does not

adversely affect outcome. An FNR of 14% is similar to

that reported in a meta-analysis of 25,000 melanoma

patients (12.5%)

[23]

and 20% FNR in 10-year follow-

up of the Multicenter Selective Lymphadenectomy

Trial (MSLT) trial in melanoma

[24]

. However, this is

on the borderline of acceptability and we should aim

to reduce this to the 7% FNR accepted in breast

cancer

[25]

. Further analysis of the factors associated

with a false-negative biopsy is warranted but initial

review of our data suggests that operator factors are

principally responsible for the FNR. It is well estab-

lished that there is a learning curve to the SN tech-

nique

[11]

.

It is of particular note that previous studies

[9,11]

indicated that SNB was less reliable for tumours in the

floor of mouth presumably due to the close proximity of

the injection site to the primary draining nodes. The

same association was not found in this study.

The major positive patient benefit of SNB is that in

this series 71% of patients were spared neck dissection

with consequent improved function and reduced

morbidity

[26,27]

. There were also 47 patients with

midline tumours who by convention would have

received bilateral neck dissection. In this group, only

eight underwent bilateral and eight unilateral dissection

based on positive SN. A low complication rate as well as

Fig. 1. Overall survival for SNB

þ

versus SNB biopsy

(p

Z

0.00083). SNB, sentinel node biopsy.

Fig. 2. Overall survival for 0, 1, or 2 positive sentinel nodes

(p

Z

0.000016).

Fig. 3. Overall survival by metastasis type: isolated tumour cells

(I) versus macrometastasis (Ma) versus micrometastasis (Mi)

(p

Z

0.0318).

C. Schilling et al. / European Journal of Cancer 51 (2015) 2777

e

2784

126